Compare OCGN & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | NATH |
|---|---|---|
| Founded | 2013 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 405.6M |
| IPO Year | 2014 | 1996 |
| Metric | OCGN | NATH |
|---|---|---|
| Price | $0.74 | $102.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.17 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 32.3K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | ★ $104,201,000.00 |
| Revenue This Year | $12.33 | N/A |
| Revenue Next Year | $10.95 | N/A |
| P/E Ratio | ★ N/A | $47.64 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $0.78 | $88.67 |
| 52 Week High | $2.73 | $110.92 |
| Indicator | OCGN | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 25.38 | 64.07 |
| Support Level | N/A | $100.68 |
| Resistance Level | $1.12 | $102.04 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 0.77 | 93.51 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Nathan's Famous Inc is a branded licensor, wholesaler and retailer of products marketed under its brand. Its products are currently marketed for sale in thousands of locations, including supermarkets, mass merchandisers and club stores, selected foodservice locations and its company-owned and franchised restaurants throughout the United States and in twenty foreign countries. It considers itself to be in the foodservice industry. It has three segments Branded Product Program, Product Licensing, Restaurant Operations, of which majority of revenue is from Branded Product Program which derives from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors. It generates majority of revenue from United States.